Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Banner image

IP LitigationLife Sciences

Survey of the Safe Harbor in the United States and Europe

December 7, 2016

IP LitigationLife Sciences

Survey of the Safe Harbor in the United States and Europe

December 7, 2016

Back to Fish's Litigation Blog

 

Fish & Richardson litigation attorney Brian Coggio recently co-authored the article “Survey of the Safe Harbor in the United States and Europe” published by Bloomberg BNA on December 2, in the Pharmaceutical Law & Industry Report.  The survey reviews the scope and history of protection afforded by the Safe Harbor including the so-called Bolar Exception, Bolar Exemption and the broad research exemptions that exist in Europe.

“Understanding the scope of the Safe Harbor in the U.S. and the regulatory research safe harbors in the EU and Canada will allow companies to take advantage of the best geographical locations in order to avoid infringement accusations in researching and developing pharmaceutical products.”

DownloadButton

Authors: Brian Coggio, Ron Vogel


The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.

Related Tags

safe harbor

Blog Authors

Headshot
Brian D. Coggio | Of Counsel

Mr. Coggio is Of Counsel to the New York office of Fish & Richardson. He has extensive law firm experience as a senior trial attorney and counselor and has litigated disputes across a wide range of technologies with a particular focus in chemical, pharmaceutical, medical device,...

Leave a Reply

Your email address will not be published. Required fields are marked *